PRENETICS PTE. LTD.

Last Updated: 31 Jan 2025

Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand, and Europa, one of the top sports distribution companies in the USA. Our clinical division is led by Insighta, our $200 million joint venture with renowned scientist Prof. Dennis Lo, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for comprehensive genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer comprehensive DNA tests. Each of Prenetics’ units synergistically enhances our global impact on health, embodying our commitment to ‘enhancing life through science’.

Country of registration	Singapore
Registration number	201712120Z
Local SIC	62011: Development of e-commerce applications
Incorporation date	3 May 2017
Company age	8 years 10 months
Official entity type	Private Limited Company
No. of officers	3

Contact

Address:

701 GEYLANG ROAD, #04-04, TEAMBUILD CENTRE, Singapore 389687

Phone number:

Access Key Decision Makers

This is the legal entity page of PRENETICS PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.

The largest company and people database for SEA & ANZ

Associated business (1)

PRENETICS
Hong Kong
View More
genetic testing
dna testing
personalized medicine
pharmacogenomics testing
personalised digital health
vitamins
supplements
nutrition
diagnostics
nutraceuticals
health and wellness
consumer healthcare
oncology
early cancer detection
clinical health
Information & Communications Technology (ICT)
Others in Information & Communications Technology (ICT)
Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand, and Europa, one of the top sports distribution companies in the USA. Our clinical division is led by Insighta, our $200 million joint venture with renowned scientist Prof. Dennis Lo, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for comprehensive genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer comprehensive DNA tests. Each of Prenetics’ units synergistically enhances our global impact on health, embodying our commitment to ‘enhancing life through science’.

This is the legal entity page of PRENETICS PTE. LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.

Financials

Auditor	BOB ENG & PARTNERS
Revenue	> 10m
Share Capital - Ordinary shares	SGD 10

Last updated: 31 Jan 2025

* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.

Discover More Companies

Lookalike companies

* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.

Frequently Asked Questions (FAQ)

What is the address of PRENETICS PTE. LTD.?
Where is PRENETICS PTE. LTD.'s headquarter?
What is PRENETICS PTE. LTD.'s contact number?
What PRENETICS PTE. LTD.'s spending power?
Does PRENETICS PTE. LTD. have a presence in the domain it operates in?